Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug
A committee of independent advisers to the Food and Drug Administration voted unanimously on Monday that the benefits outweigh the risks of the newest experimental drug for Alzheimer’s disease.
Alzheimer’s afflicts more than six million Americans. It... [464 chars]
Source: The New York Times
